TGA Update (30 September 2021)

An update from the Therapeudic Goods Administration on the potential down-scheduling of MDMA and psilocybin


Previous
Previous

Note from the founders

Next
Next

A Renaissance for Psychedelics Could Fill a Long-Standing Treatment Gap for Psychiatric Disorders